Skip to main content
Clinical Trials/NCT02876627
NCT02876627
Completed
Phase 1

The Effect of 12 Weeks of Aerobic Training Program on Erythrocyte Levels in Women With Breast Cancer After Chemotherapy

University of Isfahan0 sites30 target enrollmentFebruary 2015

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Cancer
Sponsor
University of Isfahan
Enrollment
30
Primary Endpoint
effect of exercise on CBC parameters (measured by ELISA methods)
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

Introduction: The purpose of this study was to determine the effect of twelve weeks of aerobic exercise program on erythrocyte levels in women with breast cancer after chemotherapy.

Methods: Thirty women with breast cancer after chemotherapy of Sydalshhda hospital (aged between 47-65 years) volunteered for this study, and then randomly selected an exercise (n = 15) and control (n = 15) groups. Exercise group completed a twelve-week aerobic exercise training program consisted of three sessions per week, each session lasting 30 to 60 minutes 50 to 75 percent of their maximum heart rate reserve, while the control group were followed. Blood samples including red blood cell counts (RBC), hematocrit (HCT), hemoglobin (HB), peak oxygen consumption before and after 12 weeks of aerobic exercise were measured. For analysis of data, repeated-measures analysis of variance (ANOVA) was used.

Registry
clinicaltrials.gov
Start Date
February 2015
End Date
April 2016
Last Updated
9 years ago
Study Type
Interventional
Study Design
Single Group
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Prof.Mehdi Kargarfard

Principal Investigator

University of Isfahan

Eligibility Criteria

Inclusion Criteria

  • women with breast cancer , who can do a physical, physiological and psychological test; and did not have exercise limitations due to neuromuscular and/or musculoskeletal disease; did not have any health problems that prevented maximum effort on the treadmill test.

Exclusion Criteria

  • women under erythropoietin treatments, uncontrolled cardiovascular or pulmonary diseases, uncontrolled arrhythmias, orthopedic conditions that would limit exercise participation, refusal for randomization, or participation in aerobic exercise training within 3 months before beginning the study.

Outcomes

Primary Outcomes

effect of exercise on CBC parameters (measured by ELISA methods)

Time Frame: up to 12 weeks

Secondary Outcomes

  • effect of exercise on peak oxygen consumption, measured by vo2 max test(up to 12 weeks)

Similar Trials

Completed
Not Applicable
The effect of twelve weeks of light aerobic exercise on cognitive and motor performances in women with non-severe Multiple SclerosisMultiple Sclerosis.
IRCT20231222060493N1Razi University of Kermanshah30
Completed
Not Applicable
Effect of combined exercise on appetite hormones in obese adolescensObesity.Obesity
IRCT2016012926251N1Vice Chancellor for research of Abadan University of Medical Sciences30
Completed
Not Applicable
Evaluation of the effect of aerobic exercise in patients with hypertensioWomen with hypertension with an age range of 50 to 70 years, according to the seventh report of the Joint National Committee for the Prevention, Diagnosis, Measurement and Treatment of Hypertension, in stage 1 hypertension (systolic pressure 159-140 and diastolic pressure 99-90 mm Mercury).Essential (primary) hypertension
IRCT20200815048410N1Islamic Azad University35
Unknown
Not Applicable
Impact of Aerobic Exercise on Metabolic Syndrome, Neurocognition and Empowerment in Individuals With Mental DisordersMetabolic SyndromeMental Disorders
NCT02858102Fundación Marques de Valdecilla50
Completed
Phase 4
Effect of an aerobic training program on pain, physical and functional performance as well as inflammatory response in elders with knee osteoarthritis- Preliminaries results.osteoarthritis of Knee.Physical Medicine / Rehabilitation - PhysiotherapyMusculoskeletal - OsteoarthritisInflammatory and Immune System - Other inflammatory or immune system disorders
ACTRN12609000902291Fapemig4